CCIA
SRTS icon

Campbell & Co Investment Adviser’s Sensus Healthcare SRTS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,548
Closed -$126K – 1448
2025
Q1 		$126K Sell
26,548
-4,829
-15% -$28.1K 0.01% 974
2024
Q4 		$217K Buy
+31,377
New +$230K 0.02% 946

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Campbell & Co Investment Adviser's SRTS Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 26,548 shares — an estimated $126K sold.

Campbell & Co Investment Adviser first reported a position in SRTS in Q4 2024 and held it in 2 quarters. The position peaked at $217K in Q4 2024. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

  • Campbell & Co Investment Adviser reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,548 Sensus Healthcare shares in Q2 2025, an estimated $126K.
  • Campbell & Co Investment Adviser first reported a position in Sensus Healthcare in Q4 2024 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Sensus Healthcare position peaked at $217K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.